Ambros Therapeutics is a clinical-stage biotechnology company advancing late-stage therapies for severe, underserved diseases beginning with neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1).

Arkin Entry Stage

Series A

Status

Active

Location

Irvine, CA

Let’s get in touch!